Inspire IVF PCL (BKK:IVF)
0.8100
0.00 (0.00%)
At close: Feb 10, 2026
Inspire IVF PCL Company Description
Inspire IVF Public Company Limited operates an infertility treatment center in Thailand.
The company offers intrauterine insemination, preimplantation genetic testing, intracytoplasmic sperm injection, embryo transfer, fertility preservation, preventive and regenerative medicine, health checkup, and other infertility treatments.
It provides obstetrics and gynecology examinations, consulting, and advice, as well as age management medicine, health regeneration, blood dialysis, and blood filtration services.
The company was incorporated in 2018 and is based in Bangkok, Thailand.
Inspire IVF PCL
| Country | Thailand |
| Founded | 2018 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 31 |
| CEO | Kasinee Kuldiloke |
Contact Details
Address: Ploenchit Center Building Bangkok, 10110 Thailand | |
| Phone | 66 2 251 8666 |
| Website | inspireivf.com |
Stock Details
| Ticker Symbol | IVF |
| Exchange | Stock Exchange of Thailand |
| Fiscal Year | January - December |
| Reporting Currency | THB |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Kasinee Kuldiloke | Acting Chief Operating Officer, Chief Executive Officer and Executive Director |
| Parama Rattanaubon | Chief Financial Officer |
| Sittideth Sangnual | Chief Scientific Officer and Chief Genetics Laboratory Officer |
| Dr. Santha Srisuparp | Chief Medical, Pharmaceutical and Nursing Officer |
| Chatree Siribun | Chief Embryology Laboratory Officer |